EXHIBIT 10.2(A) SEVERANCE AGREEMENT ------------------- THIS AGREEMENT, dated May , 1999, is made by and between Centocor, Inc. a Pennsylvania corporation (the "Company"), and _________ (the "Executive"). WHEREAS, the Company considers it essential to...Severance Agreement • May 17th, 1999 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
RECITALSStock Option Agreement • July 28th, 1999 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
INDEXRights Agreement • September 28th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
CENTOCOR, INC.Underwriting Agreement • February 16th, 1996 • Centocor Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.34 ASSET PURCHASE AGREEMENT dated February 11, 1998Asset Purchase Agreement • February 13th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • New York
AmongMerger Agreement • July 28th, 1999 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
Exhibit 99.1 CENTOCOR, INC. NON-QUALIFIED STOCK OPTION AGREEMENT THIS AGREEMENT is entered into as of the __________ day of __________ between Centocor, Inc., a Pennsylvania corporation (the "Company"), and __________ ("Grantee"). WHEREAS, the Board...Non-Qualified Stock Option Agreement • June 19th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of February 13, 1998 by and among CENTOCOR, INC., a Pennsylvania corporation (the "Company") and MORGAN STANLEY & CO. INCORPORATED (the "Initial...Registration Rights Agreement • May 12th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 10.2(B) Schedule of Named Executive Officers and Executive Officers who are Parties to a -------------------------------------------------------------- ------------------ Severance Agreement ------------------- Hubert J.P Schoemaker Chairman...Severance Agreement • May 17th, 1999 • Centocor Inc • In vitro & in vivo diagnostic substances
CONFIDENTIAL TREATMENT EXHIBIT 2.1 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO REGISTRANT'S APPLICATION OBJECTING TO DISCLOSURE AND REQUESTING CONFIDENTIAL...Stock and Asset Purchase Agreement • December 2nd, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
ARTICLE I DEFINITIONS -----------Distribution Agreement • May 12th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
Exhibit 10.1 THE REGISTRANT HAS REQUESTED CONFIDENTIAL TREATMENT FOR CERTAIN PORTIONS OF THIS AGREEMENT. THOSE PORTIONS HAVE BEEN OMITTED FROM THIS COPY OF THE AGREEMENT AT THE PLACES INDICATED BY (XXXX); AND HAVE BEEN FILED SEPARATELY WITH THE...Development and Manufacturing Agreement • May 17th, 1999 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
ReoPro/TM/ Distribution Agreement THIS AGREEMENT, made and effective as of August 15, 1996, (the "Effective Date") is by and between Centocor, Inc., a Pennsylvania corporation having its principal place of business at 200 Great Valley Parkway,...Distribution Agreement • March 6th, 1997 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
BACKGROUND ----------Sales and Distribution Agreement • May 14th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
EXHIBIT 5 HARKINS CUNNINGHAM 1800 One Commerce Square 2005 Market Street Philadelphia, PA 19103 (215) 851-6700 Fax (215) 851-6710 June 19, 1998Consultant Non-Qualified Stock Option Agreements • June 19th, 1998 • Centocor Inc • In vitro & in vivo diagnostic substances
BACKGROUND ----------Sales and Distribution Agreement • March 6th, 1997 • Centocor Inc • In vitro & in vivo diagnostic substances • Pennsylvania
